[{"NetIncomeLoss_1_Q2_USD":-3437000.0,"GeneralAndAdministrativeExpense_2_Q2_USD":4398000.0,"GeneralAndAdministrativeExpense_1_Q2_USD":2614000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_2_Q2_shares":5470609.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q2_shares":10499937.0,"CommitmentsAndContingencies_0_Q2_USD":null,"AccruedLiabilitiesCurrent_0_Q2_USD":1688000.0,"RestructuringReserveNoncurrent_0_Q2_USD":1435000.0,"RestrictedCashCurrent_0_Q2_USD":50000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_2_Q2_pure":0.766,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_1_Q2_pure":0.766,"RedeemableNoncontrollingInterestEquityPreferredCarryingAmount_0_Q2_USD":0.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_2_Q2_pure":0.011,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_1_Q2_pure":0.011,"PaymentsForRestructuring_2_Q2_USD":750000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":796000.0,"StockIssuedDuringPeriodValueNewIssues_1_Q2_USD":48411000.0,"ProceedsFromDivestitureOfBusinesses_2_Q2_USD":796000.0,"RestructuringReserveSettledWithoutCash2_2_Q2_USD":136000.0,"DepreciationAmortizationAndAccretionNet_2_Q2_USD":85000.0,"AssetsCurrent_0_Q2_USD":95876000.0,"DepositsAssetsCurrent_0_Q2_USD":85000.0,"RestructuringCharges_2_Q2_USD":85000.0,"TemporaryEquitySharesOutstanding_0_Q2_shares":0.0,"EquitySecuritiesFvNiGainLoss_1_Q2_USD":-281000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2_Q2_shares":2659873.0,"EquitySecuritiesFvNiGainLoss_2_Q2_USD":-281000.0,"OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentals_0_Q2_USD":8412000.0,"ResearchAndDevelopmentExpense_2_Q2_USD":6167000.0,"ResearchAndDevelopmentExpense_1_Q2_USD":3235000.0,"EquitySecuritiesFvNiUnrealizedGainLoss_2_Q2_USD":-281000.0,"TemporaryEquitySharesAuthorized_0_Q2_shares":0.0,"FinanceLeasePrincipalPayments_2_Q2_USD":0.0,"IncreaseDecreaseInAccruedLiabilities_2_Q2_USD":1153000.0,"IncomeTaxExpenseBenefit_2_Q2_USD":0.0,"IncomeTaxExpenseBenefit_1_Q2_USD":0.0,"OperatingLeasesFutureMinimumPaymentsDueInThreeYears_0_Q2_USD":2458000.0,"StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_1_Q2_USD":139576000.0,"TemporaryEquitySharesIssued_0_Q2_shares":0.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":48961000.0,"AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_1_Q2_USD":713000.0,"PaymentsOfStockIssuanceCosts_2_Q2_USD":2765000.0,"OtherAssetsCurrent_0_Q2_USD":475000.0,"GainLossOnSaleOfBusiness_2_Q2_USD":2691000.0,"GainLossOnSaleOfBusiness_1_Q2_USD":2691000.0,"OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear_0_Q2_USD":1169000.0,"IncreaseDecreaseInAccountsPayable_2_Q2_USD":814000.0,"TemporaryEquityParOrStatedValuePerShare_0_Q2_USD":0.001,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":91625000.0,"AdditionalPaidInCapitalCommonStock_0_Q2_USD":191732000.0,"Liabilities_0_Q2_USD":5492000.0,"PreferredStockSharesOutstanding_0_Q2_shares":0.0,"ConversionOfStockAmountConverted1_2_Q2_USD":139576000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q2_shares":2659873.0,"DueToRelatedPartiesCurrent_0_Q2_USD":717000.0,"OperatingLeasesFutureMinimumPaymentsDueInTwoYears_0_Q2_USD":2381000.0,"OperatingLeasesFutureMinimumPaymentsDueInFourYears_0_Q2_USD":2538000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-11786000.0,"GainLossOnDispositionOfAssets1_2_Q2_USD":2691000.0,"MarketableSecuritiesNoncurrent_0_Q2_USD":1478000.0,"LiabilitiesCurrent_0_Q2_USD":3771000.0,"AccountsPayableCurrent_0_Q2_USD":1723000.0,"NonoperatingIncomeExpense_2_Q2_USD":2414000.0,"NonoperatingIncomeExpense_1_Q2_USD":2412000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q2_USD":91968000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q2_USD":4201000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_2_Q2_pure":0.763,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_1_Q2_pure":0.763,"ProceedsFromStockOptionsExercised_2_Q2_USD":550000.0,"DefinedContributionPlanEmployerDiscretionaryContributionAmount_2_Q2_USD":0.0,"DefinedContributionPlanEmployerDiscretionaryContributionAmount_1_Q2_USD":0.0,"OtherAccruedLiabilitiesCurrent_0_Q2_USD":413000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_2_Q2_pure":0.006,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_1_Q2_pure":0.01,"RestructuringReserveCurrent_0_Q2_USD":360000.0,"PrepaidInsurance_0_Q2_USD":2509000.0,"PreferredStockSharesIssued_0_Q2_shares":0.0,"NetIncomeLoss_2_Q2_USD":-8151000.0,"RestrictedCashNoncurrent_0_Q2_USD":293000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q2_USD":208000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":37971000.0,"OperatingLeasesFutureMinimumPaymentsDueInFiveYears_0_Q2_USD":1954000.0,"EquitySecuritiesFvNi_0_Q2_USD":1478000.0,"Assets_0_Q2_USD":97647000.0,"ShareBasedCompensation_2_Q2_USD":1117000.0,"PreferredStockParOrStatedValuePerShare_0_Q2_USD":0.001,"ProceedsFromIssuanceOfCommonStock_2_Q2_USD":51176000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_Q2_USD":3644000.0,"OperatingIncomeLoss_2_Q2_USD":-10565000.0,"OperatingIncomeLoss_1_Q2_USD":-5849000.0,"RestructuringReserve_0_Q2_USD":1795000.0,"InvestmentIncomeInterest_2_Q2_USD":4000.0,"InvestmentIncomeInterest_1_Q2_USD":2000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_2_Q2_pure":null,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_1_Q2_pure":null,"LiabilitiesAndStockholdersEquity_0_Q2_USD":97647000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q2_USD":558000.0,"PreferredStockSharesAuthorized_0_Q2_shares":10000000.0,"AllocatedShareBasedCompensationExpense_2_Q2_USD":1117000.0,"AllocatedShareBasedCompensationExpense_1_Q2_USD":713000.0,"OperatingExpenses_2_Q2_USD":10565000.0,"OperatingExpenses_1_Q2_USD":5849000.0,"EarningsPerShareBasicAndDiluted_2_Q2_USD":-1.49,"EarningsPerShareBasicAndDiluted_1_Q2_USD":-0.33,"StockholdersEquity_0_Q2_USD":92155000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-99598000.0,"OperatingLeasesFutureMinimumPaymentsDue_0_Q2_USD":10500000.0,"Ticker":"VERA","CIK":"1831828","name":"VERA THERAPEUTICS, INC.","OfficialName":"Vera Therapeutics Inc. Class A Common Stock","form":"10-Q","period":"20210630","fy":"2021.0","fp":"Q2","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"633029132.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20210816"}]